Business
Xenon Pharmaceuticals to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference
BURNABY, British Columbia, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today
About this update from Xenon Pharmaceuticals Inc.
[{"type":"text","content":"BURNABY, British Columbia, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced its participation in one-on-one investor meetings as well as a virtual panel discussion at the 12th Annual Wedbush PacGrow Healthcare Conference. Panel Topic:“Got My Mind Set On You - Advancing Novel Epilepsy Targets” Date:Wednesday, August 11, 2021 Time:11:30 am – 12 pm Eastern Time Panelist:Dr. Simon Pimstone, Executive Chair of the Board Additional details along with a link to the live webcast can be found on the “Investors” section of Xenon’s website at http://investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event for 30 days. The above listed dates and times are subject to change. About Xenon Pharmaceuticals Inc. We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com. “Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner. Investor/Media Contact:Maria McCleanXenon Pharmaceuticals Inc.Phone: 604.484.3353Email: [email protected] \nSource: Xenon Pharmaceuticals Inc.","length":3954,"tagName":"div"}]